The health gains and cost savings of dietary salt reduction interventions, with equity and age distributional aspects

BMC Public Health

Volumn 16, Issue 1, 2016, Pages

  Nghiem, Nhung ^a   Blakely, Tony ^a   Cobiac, Linda J ^b   Cleghorn, Christine L ^a   Wilson, Nick ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Bread; Cardiovascular disease; Dietary salt; Modelling; Salt substitution; Sodium

Indexed keywords

MAGNESIUM DERIVATIVE; POTASSIUM DERIVATIVE; SALT INTAKE;

ADMINISTRATION AND DOSAGE; ADULT; AGE DISTRIBUTION; AGED; ANALYSIS; CARDIOVASCULAR DISEASES; CHEMISTRY; COST BENEFIT ANALYSIS; COST CONTROL; DIET; ECONOMICS; EPIDEMIOLOGY; FAST FOOD; FEMALE; HUMAN; MALE; MARKOV CHAIN; MIDDLE AGED; NEW ZEALAND; OCEANIC ANCESTRY GROUP; QUALITY ADJUSTED LIFE YEAR; RISK FACTOR; SALT INTAKE; THEORETICAL MODEL;

ADULT; AGE DISTRIBUTION; AGED; CARDIOVASCULAR DISEASES; COST SAVINGS; COST-BENEFIT ANALYSIS; DIET; FAST FOODS; FEMALE; HUMANS; MAGNESIUM COMPOUNDS; MALE; MARKOV CHAINS; MIDDLE AGED; MODELS, THEORETICAL; NEW ZEALAND; OCEANIC ANCESTRY GROUP; POTASSIUM COMPOUNDS; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS; SODIUM CHLORIDE, DIETARY;

EID: 84969793921     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-016-3102-1     Document Type: Article

References (69)

1. GBD 2013 Risk Factors Collaborators, Forouzanfar M, Alexander L, Anderson H, Bachman V, Biryukov S, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;386:2287-323.
2. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377(9775):1438-47.
3. Di Cesare M, Khang YH, Asaria P, Blakely T, Cowan MJ, Farzadfar F, et al. Inequalities in non-communicable diseases and effective responses. Lancet. 2013;381(9866):585-97.
4. WHO. Guideline. Sodium intake for adults and children. Geneva: World Health Organization; 2012. http://www.who.int/nutrition/publications/guidelines/sodium-intake-printversion.pdf Accessed 6 May 2016.
5. Nghiem N, Blakely T, Cobiac LJ, Pearson AL, Wilson N. Health and economic impacts of eight different dietary salt reduction interventions. PLoS One. 2015;10(4), e0123915.
6. He FJ, Li J, Macgregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev. 2013;4, CD004937.
7. Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ. 2013;346:f1326.
8. Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ. 2007;334(7599):885-8.
9. Cook NR, Appel LJ, Whelton PK. Lower levels of sodium intake and reduced cardiovascular risk. Circulation. 2014;129(9):981-9.
10. Chang HY, Hu YW, Yue CS, Wen YW, Yeh WT, Hsu LS, et al. Effect of potassium-enriched salt on cardiovascular mortality and medical expenses of elderly men. Am J Clin Nutr. 2006;83(6):1289-96.
11. Farquhar WB, Edwards DG, Jurkovitz CT, Weintraub WS. Dietary sodium and health: more than just blood pressure. J Am Coll Cardiol. 2015;65(10):1042-50.
12. Siervo M, Lara J, Chowdhury S, Ashor A, Oggioni C, Mathers JC. Effects of the Dietary Approach to Stop Hypertension (DASH) diet on cardiovascular risk factors: a systematic review and meta-analysis. Br J Nutr. 2014;1-15.
13. Poggio R, Gutierrez L, Matta MG, Elorriaga N, Irazola V, Rubinstein A. Daily sodium consumption and CVD mortality in the general population: systematic review and meta-analysis of prospective studies. Public Health Nutr. 2015;18(4):695-704.
14. Li N, Prescott J, Wu Y, Barzi F, Yu X, Zhao L, et al. The effects of a reduced-sodium, high-potassium salt substitute on food taste and acceptability in rural northern China. Br J Nutr. 2009;101(7):1088-93.
15. Li N, Yan LL, Niu W, Labarthe D, Feng X, Shi J, et al. A large-scale cluster randomized trial to determine the effects of community-based dietary sodium reduction - the China Rural Health Initiative Sodium Reduction Study. Am Heart J. 2013;166(5):815-22.
16. Peng YG, Li W, Wen XX, Li Y, Hu JH, Zhao LC. Effects of salt substitutes on blood pressure: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2014;100(6):1448-54.
17. Martikainen JA, Soini EJ, Laaksonen DE, Niskanen L. Health economic consequences of reducing salt intake and replacing saturated fat with polyunsaturated fat in the adult Finnish population: estimates based on the FINRISK and FINDIET studies. Eur J Clin Nutr. 2011;65(10):1148-55.
18. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010;362(7):590-9.
19. 3 programme. Wellington: Department of Public Health, University of Otago; 2014. Available at: http://www.otago.ac.nz/wellington/otago070188.pdf; Accessed 6 May 2016.
20. Ministry of Health. Ways and means: a report on methodology from the New Zealand burden of disease, injury and risk study, 2006-2016. Wellington: Ministry of Health; 2013. Available at: http://www.health.govt.nz/publication/ways-and-means-report-methodology-new-zealand-burden-disease-injury-and-risk-study-2006-2016. Accessed 6 May 2016.
21. Woodward A, Blakely T. The healthy country? a history of life and death in New Zealand. Auckland: Auckland University Press; 2014.
22. OECD. New international comparisons of GDP and consumption based on purchasing power parities for the year 2011. Paris: OECD; 2013.
23. Baltussen R, Adam T, Tan-Torres Edejer T, Hutubessy R, Acharya A, et al. Methods for generalized cost-effectiveness analysis. In: Tan-Torres Edejer T, Baltussen R, Adam T, Hutubessy R, Acharya A, et al.; editors. Making choices in health: WHO guide to cost-effectiveness analysis. Geneva: World Health Organization; 2003.
24. Blakely T, Atkinson J, Kvizhinadze G, Nghiem N, McLeod H, Davies A, et al. Updated New Zealand health system cost estimates from health events by sex, age and proximity to death: further improvements in the age of 'big data'. N Z Med J. 2015;128(1422):13-23.
25. Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the global burden of disease study 2010. Lancet. 2012;380(9859):2129-43.
26. Blakely T, Woodward A. Living longer, living healthier? Latest Official Report on independent life expectancy in NZ. Public Health Expert [Blog] (31 August, 2015). Available at: https://blogs.otago.ac.nz/pubhealthexpert/2015/08/31/living-longer-living-healthier-latest-official-report-on-independent-life-expectancy-in-nz. Accessed 6 May 2016.
27. Geleijnse JM, Witteman JC, Bak AA, den Breeijen JH, Grobbee DE. Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension. BMJ. 1994;309(6952):436-40.
28. He FJ, Jenner KH, Macgregor GA. WASH-world action on salt and health. Kidney Int. 2010;78(8):745-53.
29. Dunford EK, Eyles H, Ni Mhurchu C, Webster JL, Neal BC. Changes in the sodium content of bread in Australia and New Zealand between 2007 and 2010: implications for policy. Med J Aust. 2011;195(6):346-9.
30. Woodward E, Eyles H, Ni Mhurchu C. Key opportunities for sodium reduction in New Zealand processed foods. Aust N Z J Public Health. 2012;36(1):84-9.
31. Butler M. Salt reduction targets agreed. Canberra: Australian Government Department of Health and Ageing; 2010.
32. 3 programme. Wellington: Department of Public Health, University of Otago; 2014. Available at: http://www.otago.ac.nz/wellington/otago070189.pdf Accessed 6 May 2016.
33. Barendregt J, Oortmarssen GJ, Vos T, Murray CJL. A generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Popul Health Metr. 2003;1(1):4.
34. Blakely T, Cobiac LJ, Cleghorn CL, Pearson AL, van der Deen FS, Kvizhinadze G, et al. Health, health inequality, and cost impacts of annual increases in tobacco tax: Multistate life table modeling in New Zealand. PLoS Med. 2015;12(7), e1001856.
35. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood-pressure? 1. Analysis of observational data among populations. BMJ. 1991;302(6780):811-5.
36. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903-13.
37. Unilever. Reducing salt (circa 2015). Available at: https://www.unilever.com/sustainable-living/what-matters-to-you/reducing-salt.html Accessed 6 May 2016.
38. Choi SE, Brandeau ML, Basu S. Expansion of the national salt reduction initiative: a mathematical model of benefits and risks of population-level sodium reduction. Med Decis Making. 2016;36(1):72-85.
39. D'Elia L, Rossi G, Ippolito R, Cappuccio FP, Strazzullo P. Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr. 2012;31(4):489-98.
40. Smyth A, O'Donnell MJ, Yusuf S, Clase CM, Teo KK, Canavan M, et al. Sodium intake and renal outcomes: A systematic review. Am J Hypertens. 2014;27:1277-84.
41. Aburto NJ, Hanson S, Gutierrez H, Hooper L, Elliott P, Cappuccio FP. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ. 2013;346:f1378.
42. Fang X, Liang C, Li M, Montgomery S, Fall K, Aaseth J, et al. Dose-response relationship between dietary magnesium intake and cardiovascular mortality: A systematic review and dose-based meta-regression analysis of prospective studies. J Trace Elem Med Biol. 2016. doi: 10.1016/j.jtemb.2016.03.014.
43. Sarrafzadegan N, Khosravi-Boroujeni H, Lotfizadeh M, Pourmogaddas A, Salehi-Abargouei A. Magnesium status and the metabolic syndrome: A systematic review and meta-analysis. Nutr. 2016;32(4):409-17.
44. Price CT, Langford JR, Liporace FA. Essential nutrients for bone health and a review of their availability in the average North American diet. Open Orthop J. 2012;6:143-9.
45. Watson PE, McDonald BW. The association of maternal diet and dietary supplement intake in pregnant New Zealand women with infant birthweight. Eur J Clin Nutr. 2010;64(2):184-93.
46. Bolhuis DP, Temme EH, Koeman FT, Noort MW, Kremer S, Janssen AM. A salt reduction of 50% in bread does not decrease bread consumption or increase sodium intake by the choice of sandwich fillings. J Nutr. 2011;141(12):2249-55.
47. Dixon S. The employment and income effects of eight chronic and acute health conditions (treasury working paper 15/15). Wellington: NZ Treasury; 2015. http://www.treasury.govt.nz/publications/research-policy/wp/2015/15-15. Accessed 6 May 2016.
48. Hofman K, Tollman S. Population health in South Africa: a view from the salt mines. Lancet Global Health. 2013;1:e66-7.
49. European Commission. Survey on members states implementation of the EU salt reduction framework: directorate-general health and consumers. 2012. Available at: http://ec.europa.eu/health/nutrition-physical-activity/docs/salt-report1-en.pdf Accessed 6 May 2016.
50. He FJ, Brinsden HC, Macgregor GA. Salt reduction in the United Kingdom: a successful experiment in public health. J Hum Hypertens. 2014;28:345-52.
51. Pietinen P, Mannisto S, Valsta LM, Sarlio-Lahteenkorva S. Nutrition policy in Finland. Public Health Nutr. 2010;13(6A):901-6.
52. Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet. 2003;361(9359):717-25.
53. Palar K, Sturm R. Potential societal savings from reduced sodium consumption in the U.S. adult population. Am J Health Promot. 2009;24(1):49-57.
54. Smith-Spangler CM, Juusola JL, Enns EA, Owens DK, Garber AM. Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis. Ann Int Med. 2010;152(8):481-7. W170-483.
55. Cobiac LJ, Vos T, Veerman JL. Cost-effectiveness of interventions to reduce dietary salt intake. Heart. 2010;96(23):1920-5.
56. Barton P, Andronis L, Briggs A, McPherson K, Capewell S. Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study. BMJ. 2011;343:d4044.
57. Wang G, Bowman BA. Recent economic evaluations of interventions to prevent cardiovascular disease by reducing sodium intake. Curr Atheroscler Rep. 2013;15(9):349.
58. Cobiac LJ, Magnus A, Lim S, Barendregt JJ, Carter R, Vos T. Which interventions offer best value for money in primary prevention of cardiovascular disease? PLoS One. 2012;7(7), e41842.
59. Dodhia H, Phillips K, Zannou MI, Airoldi M, Bevan G. Modelling the impact on avoidable cardiovascular disease burden and costs of interventions to lower SBP in the England population. J Hypertens. 2012;30(1):217-26.
60. McLean R, Williams S, Mann J, Parnell W. How much salt are we eating? Estimates of New Zealand population sodium from the 2008/2009 Adult Nutrition Survey. Queenstown: Joint Annual Scientific Meeting of the Australian and New Zealand Nutrition Societies; 2011.
61. McLean RM, Mann JI, Hoek J. World Salt Awareness Week: more action needed in New Zealand. N Z Med J. 2011;124(1332):68-76.
62. Huang L, Crino M, Wu JH, Woodward M, Barzi F, Land MA, et al. Mean population salt intake estimated from 24-h urine samples and spot urine samples: a systematic review and meta-analysis. Int J Epidemiol. 2016.
63. Ministry of Health. Food and Nutrition Monitoring Report 2006. Wellington: Ministry of Health; 2006.
64. McLean RM, Williams S, Mann JI, Miller JC, Parnell WR. Blood pressure and hypertension in New Zealand: results from the 2008/09 Adult Nutrition Survey. N Z Med J. 2013;126(1372):1-14.
65. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338(191):b1665.
66. Wilson N. Background technical details on mandatory interventions used in sodium reduction modelling for cardiovascular disease prevention. Wellington: Department of Public Health, University of Otago; 2014. http://www.otago.ac.nz/wellington/otago072196.pdf Accessed 6 May 2016.
67. Wilson N, Nghiem N, Foster R, Cobiac L, Blakely T. Estimating the cost of new public health legislation. Bull World Health Organ. 2012;90:532-9.
68. BODE3 Programme. Results for the cost of making a new law, all in $NZ. 2012. http://www.otago.ac.nz/wellington/otago033080.pdf Accessed 6 May 2016.
69. Wilson N, Edwards R, Parry R. A persisting secondhand smoke hazard in urban public places: results from fine particulate (PM2.5) air sampling. N Z Med J. 2011;124(1330):34-47.